Published in N Engl J Med on July 10, 1986
Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant (2009) 5.10
Respiratory syncytial virus infection in adults. Clin Microbiol Rev (2000) 3.16
Respiratory tract reinfections by the new human Metapneumovirus in an immunocompromised child. Emerg Infect Dis (2002) 3.13
Recombinant respiratory syncytial virus bearing a deletion of either the NS2 or SH gene is attenuated in chimpanzees. J Virol (1999) 2.80
Applicability of a real-time quantitative PCR assay for diagnosis of respiratory syncytial virus infection in immunocompromised adults. J Clin Microbiol (2003) 2.59
Progress in understanding and controlling respiratory syncytial virus: still crazy after all these years. Virus Res (2011) 2.51
Hospital epidemiology and infection control in acute-care settings. Clin Microbiol Rev (2011) 2.22
Comparison of directigen RSV with viral isolation and direct immunofluorescence for the identification of respiratory syncytial virus. J Clin Microbiol (1990) 2.15
Detection, pathogenesis, and therapy of respiratory syncytial virus infections. Clin Microbiol Rev (1988) 1.92
Neutralization of respiratory syncytial virus by individual and mixtures of F and G protein monoclonal antibodies. J Virol (1988) 1.91
Bronchiolitis. BMJ (1995) 1.84
Respiratory syncytial virus infection: immune response, immunopathogenesis, and treatment. Clin Microbiol Rev (1999) 1.83
Randomised double blind placebo controlled trial of prednisolone in children admitted to hospital with respiratory syncytial virus bronchiolitis. Thorax (1997) 1.69
Replication-competent or attenuated, nonpropagating vesicular stomatitis viruses expressing respiratory syncytial virus (RSV) antigens protect mice against RSV challenge. J Virol (2001) 1.58
Risk factors for severe respiratory syncytial virus lower respiratory tract infection. Open Microbiol J (2011) 1.45
Value of bronchoalveolar lavage in the management of severe acute pneumonia and interstitial pneumonitis in the immunocompromised child. Thorax (1987) 1.33
Human genetic factors and respiratory syncytial virus disease severity. Clin Microbiol Rev (2008) 1.30
Pulmonary immunity and immunopathology: lessons from respiratory syncytial virus. Expert Rev Vaccines (2008) 1.23
Multiplex assay for detection of strain-specific antibodies against the two variable regions of the G protein of respiratory syncytial virus. Clin Diagn Lab Immunol (2002) 1.22
Role of T-lymphocyte subsets in recovery from respiratory syncytial virus infection in calves. J Virol (1995) 1.21
Genetic relatedness of infecting and reinfecting respiratory syncytial virus strains identified in a birth cohort from rural Kenya. J Infect Dis (2012) 1.20
Respiratory syncytial virus infection in C57BL/6 mice: clearance of virus from the lungs with virus-specific cytotoxic T cells. J Virol (1991) 1.20
Detection of respiratory syncytial virus in adults with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2005) 1.20
Replication and clearance of respiratory syncytial virus: apoptosis is an important pathway of virus clearance after experimental infection with bovine respiratory syncytial virus. Am J Pathol (2002) 1.17
Reliability of two new test kits for rapid diagnosis of respiratory syncytial virus infection. J Clin Microbiol (1991) 1.14
Role of T cells in virus control and disease after infection with pneumonia virus of mice. J Virol (2008) 1.14
Nosocomial transmission of respiratory syncytial virus in immunocompromised adults. J Clin Microbiol (1991) 1.09
Characterization of a novel respiratory syncytial virus-specific human cytotoxic T-lymphocyte epitope. J Virol (2000) 1.09
Identification of a novel human leucocyte antigen-A*01-restricted cytotoxic T-lymphocyte epitope in the respiratory syncytial virus fusion protein. Immunology (2003) 1.09
Protective and dysregulated T cell immunity in RSV infection. Curr Opin Virol (2013) 1.08
Mixed viral infections: detection and management. Clin Microbiol Rev (1994) 1.05
Handwashing and cohorting in prevention of hospital acquired infections with respiratory syncytial virus. Arch Dis Child (1991) 1.04
Local variability in respiratory syncytial virus disease severity. Arch Dis Child (1997) 1.04
Epidemiology and prevention of pediatric viral respiratory infections in health-care institutions. Emerg Infect Dis (2001) 1.02
Subversion of pulmonary dendritic cell function by paramyxovirus infections. J Immunol (2009) 1.02
Viral etiologies of lower respiratory tract infections among Egyptian children under five years of age. BMC Infect Dis (2012) 1.02
Viral infection of the lung: host response and sequelae. J Allergy Clin Immunol (2013) 1.01
Diagnosis of respiratory syncytial virus infection. Open Microbiol J (2011) 1.01
Overcoming T cell-mediated immunopathology to achieve safe RSV vaccination. Future Virol (2008) 1.01
A decade of respiratory syncytial virus epidemiology and prophylaxis: translating evidence into everyday clinical practice. Can Respir J (2011) 1.01
Inability to evoke a long-lasting protective immune response to respiratory syncytial virus infection in mice correlates with ineffective nasal antibody responses. J Virol (2003) 1.00
Respiratory viral infections in hematopoietic stem cell and solid organ transplant recipients. Semin Respir Crit Care Med (2011) 1.00
Inter-society consensus document on treatment and prevention of bronchiolitis in newborns and infants. Ital J Pediatr (2014) 0.99
Use of intravenous gamma globulin to passively immunize high-risk children against respiratory syncytial virus: safety and pharmacokinetics. The RSVIG Study Group. Antimicrob Agents Chemother (1991) 0.99
Primary human mDC1, mDC2, and pDC dendritic cells are differentially infected and activated by respiratory syncytial virus. PLoS One (2011) 0.99
Detection of antibodies to respiratory syncytial virus attachment and nucleocapsid proteins with recombinant baculovirus-expressed antigens. J Clin Microbiol (1997) 0.99
Management of acute bronchiolitis. Arch Dis Child (1994) 0.98
Cytokine (IL-8, IL-6, TNF-alpha) and soluble TNF receptor-I release from human peripheral blood mononuclear cells after respiratory syncytial virus infection. Immunology (1995) 0.97
Hyperimmune globulins in prevention and treatment of respiratory syncytial virus infections. Clin Microbiol Rev (1995) 0.97
Respiratory hospitalizations and respiratory syncytial virus prophylaxis in special populations. Eur J Pediatr (2011) 0.97
Acute bronchiolitis in infancy: treatment and prognosis. Thorax (1989) 0.96
Respiratory syncytial virus: current progress in vaccine development. Viruses (2013) 0.95
Neutralizing anti-F glycoprotein and anti-substance P antibody treatment effectively reduces infection and inflammation associated with respiratory syncytial virus infection. J Virol (2002) 0.95
Lymphocyte apoptosis in acute respiratory syncytial virus bronchiolitis. Clin Exp Immunol (2004) 0.94
Influence of respiratory syncytial virus strain differences on pathogenesis and immunity. Curr Top Microbiol Immunol (2013) 0.93
Mucosal delivery of a double-stapled RSV peptide prevents nasopulmonary infection. J Clin Invest (2014) 0.92
Immunity to RSV in Early-Life. Front Immunol (2014) 0.92
RSV-specific airway resident memory CD8+ T cells and differential disease severity after experimental human infection. Nat Commun (2015) 0.92
Parainfluenza virus infections in children with hematologic malignancies. Pediatr Infect Dis J (2011) 0.90
Recognition of bovine respiratory syncytial virus proteins by bovine CD8+ T lymphocytes. Immunology (2003) 0.90
In vivo selection of respiratory syncytial viruses resistant to palivizumab. J Virol (2005) 0.89
Identification of immunodominant epitopes derived from the respiratory syncytial virus fusion protein that are recognized by human CD4 T cells. J Virol (2003) 0.88
Role of ECMO in the treatment of respiratory syncytial virus bronchiolitis: a collaborative report. Arch Dis Child Fetal Neonatal Ed (1995) 0.87
Effects of aging on the adaptive immune response to respiratory virus infections. Aging health (2009) 0.86
Mucosal delivery of a vectored RSV vaccine is safe and elicits protective immunity in rodents and nonhuman primates. Mol Ther Methods Clin Dev (2015) 0.86
Phenotypic analysis of local cellular responses in calves infected with bovine respiratory syncytial virus. Immunology (1999) 0.86
Prospective detection of respiratory pathogens in symptomatic children with cancer. Pediatr Infect Dis J (2013) 0.85
Differential response of human naive and memory/effector T cells to dendritic cells infected by respiratory syncytial virus. Clin Exp Immunol (2007) 0.85
Palivizumab: a review of its use in the protection of high risk infants against respiratory syncytial virus (RSV). Biologics (2007) 0.85
Hospital infection control in hematopoietic stem cell transplant recipients. Emerg Infect Dis (2001) 0.85
Epitope-specific regulatory CD4 T cells reduce virus-induced illness while preserving CD8 T-cell effector function at the site of infection. J Virol (2010) 0.83
Respiratory syncytial virus infections in infants affected by primary immunodeficiency. J Immunol Res (2014) 0.83
Respiratory Syncytial Virus: Infection, Detection, and New Options for Prevention and Treatment. Clin Microbiol Rev (2017) 0.83
Respiratory syncytial virus, an ongoing medical dilemma: an expert commentary on respiratory syncytial virus prophylactic and therapeutic pharmaceuticals currently in clinical trials. Influenza Other Respir Viruses (2015) 0.83
Neutrophil TLR4 expression is reduced in the airways of infants with severe bronchiolitis. Thorax (2009) 0.82
Ribavirin in respiratory syncytial virus infection. A double blind placebo controlled trial is needed. Arch Dis Child (1988) 0.82
Primary cytotoxic T-cell responses to bovine respiratory syncytial virus in calves. Immunology (1996) 0.82
Transmission of surfactant protein variants and haplotypes in children hospitalized with respiratory syncytial virus. Pediatr Res (2009) 0.82
Vaccines against respiratory syncytial virus: The time has finally come. Vaccine (2016) 0.81
Pediatric human immunodeficiency virus infection. Clin Microbiol Rev (1996) 0.81
Kinetics of Respiratory Syncytial Virus (RSV) Memphis Strain 37 (M37) Infection in the Respiratory Tract of Newborn Lambs as an RSV Infection Model for Human Infants. PLoS One (2015) 0.80
A Numerically Subdominant CD8 T Cell Response to Matrix Protein of Respiratory Syncytial Virus Controls Infection with Limited Immunopathology. PLoS Pathog (2016) 0.80
Development of local immunity: role in mechanisms of protection against or pathogenesis of respiratory syncytial viral infections. Lung (1990) 0.80
Pharmacokinetics-pharmacodynamics of a respiratory syncytial virus fusion inhibitor in the cotton rat model. Antimicrob Agents Chemother (2010) 0.79
Genomewide association analysis of respiratory syncytial virus infection in mice. J Virol (2009) 0.79
Ferrets as a Novel Animal Model for Studying Human Respiratory Syncytial Virus Infections in Immunocompetent and Immunocompromised Hosts. Viruses (2016) 0.79
Detection of respiratory syncytial virus in nasopharyngeal secretions by DNA-RNA hybridization. J Clin Microbiol (1989) 0.78
Targeting CD137 enhances vaccine-elicited anti-respiratory syncytial virus CD8+ T cell responses in aged mice. J Immunol (2013) 0.78
Biomarkers of respiratory syncytial virus (RSV) infection: specific neutrophil and cytokine levels provide increased accuracy in predicting disease severity. Paediatr Respir Rev (2015) 0.78
Protein-Protein Interactions of Viroporins in Coronaviruses and Paramyxoviruses: New Targets for Antivirals? Viruses (2015) 0.77
Acute viral bronchiolitis in infancy: epidemiology and management. Lung (1990) 0.77
The effect of steroid use in hospitalized adults with respiratory syncytial virus-related illness. Chest (2011) 0.77
Weaning infants with respiratory syncytial virus from mechanical ventilation through a fuzzy-logic controller. AMIA Annu Symp Proc (2003) 0.77
Human rhinovirus C infections in pediatric hematology and oncology patients. Pediatr Transplant (2014) 0.77
In situ evolution of virus-specific cytotoxic T cell responses in the lung. J Virol (2013) 0.77
Identification of a Human Respiratory Syncytial Virus Cell Entry Inhibitor by Using a Novel Lentiviral Pseudotype System. J Virol (2015) 0.75
Respiratory syncytial virus induces phosphorylation of mTOR at ser2448 in CD8 T cells from nasal washes of infected infants. Clin Exp Immunol (2015) 0.75
Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med (1999) 6.92
Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group. N Engl J Med (1993) 5.67
Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection. A randomized double-blind study. N Engl J Med (1983) 5.41
Clinically useful method for the isolation of respiratory syncytial virus. J Infect Dis (1975) 5.00
Serum IL-6 level and the development of disability in older persons. J Am Geriatr Soc (1999) 4.84
A method for assessing drug therapy appropriateness. J Clin Epidemiol (1992) 4.36
An unusual solitary lesion of secondary syphilis. Arch Dermatol (1967) 3.95
Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01. Blood (2001) 3.93
Respiratory syncytial viral infection in infants with congenital heart disease. N Engl J Med (1982) 3.93
Practice guideline for the management of infants and children 0 to 36 months of age with fever without source. Agency for Health Care Policy and Research. Ann Emerg Med (1993) 3.67
A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. Am J Med (1996) 3.53
Febrile infants at low risk for serious bacterial infection--an appraisal of the Rochester criteria and implications for management. Febrile Infant Collaborative Study Group. Pediatrics (1994) 3.38
Circulation patterns of genetically distinct group A and B strains of human respiratory syncytial virus in a community. J Gen Virol (1998) 3.06
Genetic basis of resistance to rimantadine emerging during treatment of influenza virus infection. J Virol (1988) 2.84
Validation of tetrapolar bioelectrical impedance method to assess human body composition. J Appl Physiol (1985) (1986) 2.77
On the importance of helping families: policy implications from a national study. Ment Retard (1993) 2.71
The clinical relevance of 'CSF viral culture'. A two-year experience with aseptic meningitis in Rochester, NY. JAMA (1982) 2.67
Superoxide generation by digitonin-stimulated guinea pig granulocytes. A basis for a continuous assay for monitoring superoxide production and for the study of the activation of the generating system. J Clin Invest (1978) 2.66
Deficiency of a granulocyte-membrane glycoprotein (gp150) in a boy with recurrent bacterial infections. N Engl J Med (1982) 2.47
Respiratory syncytial virus infections in infants: quantitation and duration of shedding. J Pediatr (1976) 2.45
Ribavirin treatment of respiratory syncytial viral infection in infants with underlying cardiopulmonary disease. JAMA (1985) 2.34
Association of interleukin-6 and other biologic variables with depression in older people living in the community. J Am Geriatr Soc (1999) 2.31
Low blood pressure and the risk of dementia in very old individuals. Neurology (2003) 2.30
Primary human herpesvirus 6 infection in young children. N Engl J Med (1992) 2.30
Functional changes in human leukemic cell line HL-60. A model for myeloid differentiation. J Cell Biol (1979) 2.28
Inhalation anthrax in a home craftsman. Hum Pathol (1978) 2.28
Respiratory syncytial virus infection in adults: clinical, virologic, and serial pulmonary function studies. Ann Intern Med (1978) 2.25
Depression in elderly hospitalized patients with medical illness. Arch Intern Med (1988) 2.18
Do older women use estrogen replacement? Data from the Duke Established Populations for Epidemiologic Studies of the Elderly (EPESE) J Am Geriatr Soc (1996) 2.17
Respiratory syncytial virus and premature infants born at 32 weeks' gestation or earlier: hospitalization and economic implications of prophylaxis. Arch Pediatr Adolesc Med (2000) 2.15
Rapid detection of respiratory syncytial virus with a monoclonal antibody. J Clin Microbiol (1983) 2.13
Hepatic sulfite oxidase. A functional role for molybdenum. J Biol Chem (1971) 2.13
Circulation patterns of group A and B human respiratory syncytial virus genotypes in 5 communities in North America. J Infect Dis (2000) 2.13
A summated score for the medication appropriateness index: development and assessment of clinimetric properties including content validity. J Clin Epidemiol (1994) 2.05
Interferon production in children with respiratory syncytial, influenza, and parainfluenza virus infections. J Pediatr (1978) 2.01
Respiratory syncytial virus infections within families. N Engl J Med (1976) 1.99
Long-term results of Dana-Farber Cancer Institute ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985-2000). Leukemia (2009) 1.99
Severity of respiratory syncytial virus infection is related to virus strain. J Infect Dis (1997) 1.98
Missed opportunities for childhood vaccinations in office practices and the effect on vaccination status. Pediatrics (1993) 1.97
Effect of a geriatric consultation team on functional status of elderly hospitalized patients. A randomized, controlled clinical trial. Ann Intern Med (1989) 1.94
Purification and binding properties of human platelet factor four. J Biol Chem (1976) 1.94
Viral shedding patterns of children with influenza B infection. J Infect Dis (1979) 1.91
Possible transmission by fomites of respiratory syncytial virus. J Infect Dis (1980) 1.87
Evaluation of new anti-infective drugs for the treatment of respiratory tract infections. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis (1992) 1.86
Nosocomial respiratory syncytial virus infections. N Engl J Med (1975) 1.85
Modes of transmission of respiratory syncytial virus. J Pediatr (1981) 1.84
Identification of a second class of IgG Fc receptors on human neutrophils. A 40 kilodalton molecule also found on eosinophils. J Exp Med (1986) 1.82
Neonatal respiratory syncytial virus infection. N Engl J Med (1979) 1.82
Religious coping and depression among elderly, hospitalized medically ill men. Am J Psychiatry (1992) 1.82
Children with influenza A infection: treatment with rimantadine. Pediatrics (1987) 1.80
Superoxide production by digitonin-stimulated guinea pig granulocytes. The effects of N-ethyl maleimide, divalent cations; and glycolytic and mitochondrial inhibitors on the activation of the superoxide generating system. J Clin Invest (1978) 1.79
Activity and activation of the granulocyte superoxide-generating system. Blood (1980) 1.77
Variable adherence of fimbriated Haemophilus influenzae type b to human cells. Infect Immun (1985) 1.77
Is underimmunization a marker for insufficient utilization of preventive and primary care? Arch Pediatr Adolesc Med (1995) 1.77
Immunization practices of pediatricians and family physicians in the United States. Pediatrics (1994) 1.75
Identification of infants unlikely to have serious bacterial infection although hospitalized for suspected sepsis. J Pediatr (1985) 1.73
Anemia and hemoglobin levels in older persons: relationship with age, gender, and health status. J Am Geriatr Soc (1992) 1.73
Correlation between membrane potential changes and superoxide production in human granulocytes stimulated by phorbol myristate acetate. Evidence for defective activation in chronic granulomatous disease. J Biol Chem (1980) 1.71
An occidental case of cardiomyopathy and selenium deficiency. N Engl J Med (1981) 1.69
Isolation of Aleutian disease virus of mink in cell culture. Intervirology (1977) 1.68
Comparative pharmacokinetic studies of three asparaginase preparations. J Clin Oncol (1993) 1.65
Molecular basis of the biological function of molybdenum. Effect of tungsten on xanthine oxidase and sulfite oxidase in the rat. J Biol Chem (1974) 1.65
Early ribavirin treatment of respiratory syncytial viral infection in high-risk children. J Pediatr (1990) 1.64
White matter abnormalities in mobility-impaired older persons. Neurology (2000) 1.61
Respiratory syncytial virus infection in inbred mice. Infect Immun (1979) 1.60
Risk of secondary bacterial infection in infants hospitalized with respiratory syncytial viral infection. J Pediatr (1988) 1.60
Variation in severity of respiratory syncytial virus infections with subtype. J Pediatr (1990) 1.60
Results of Dana-Farber Cancer Institute Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1981-1995). Leukemia (2000) 1.58
Economic evaluation of respiratory syncytial virus infection in Canadian children: a Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) study. J Pediatr (1997) 1.57
Hepatic sulfite oxidase. Purification and properties. J Biol Chem (1971) 1.57
Photo-onycholysis due to tetracycline hydrochloride and doxycycline. Arch Dermatol (1971) 1.56
Somatic mutation and recombination test in Drosophila melanogaster. Environ Mutagen (1984) 1.56
Assessment of readiness to transfer to adult care for adolescents with cystic fibrosis. Child Health Care (1989) 1.56
Benzodiazepine use and cognitive function among community-dwelling elderly. Clin Pharmacol Ther (1998) 1.55
Racial differences in use of cancer prevention services among older Americans. J Am Geriatr Soc (2000) 1.55
Influenza surveillance in community-dwelling elderly compared with children. Arch Fam Med (1997) 1.55
Kawasaki syndrome: description of two outbreaks in the United States. N Engl J Med (1981) 1.52
Comorbidity of five chronic health conditions in elderly community residents: determinants and impact on mortality. J Gerontol A Biol Sci Med Sci (2000) 1.52
Validation of dual x-ray absorptiometry for body-composition assessment of rats exposed to dietary stressors. Nutrition (2001) 1.52
Cellular localization of human herpesvirus-6 in the brains of children with AIDS encephalopathy. J Neurovirol (1995) 1.52
Immunization with glycoprotein subunits of respiratory syncytial virus to protect cotton rats against viral infection. J Infect Dis (1987) 1.51
Infectivity of respiratory syncytial virus by various routes of inoculation. Infect Immun (1981) 1.50
Variability of plasma IL-6 and crosslinked fibrin dimers over time in community dwelling elderly subjects. Am J Clin Pathol (1994) 1.46
Do white cells in stored blood components reduce the likelihood of posttransfusion bacterial sepsis? Transfusion (1991) 1.46
Nosocomial influenza infection as a cause of intercurrent fevers in infants. Pediatrics (1975) 1.46
Implications of the Canada youth and AIDS study for health care providers. CMAJ (1990) 1.44
Human kidney proximal tubules are the main source of plasma glutathione peroxidase. Am J Physiol (1994) 1.43
Appropriateness of medication prescribing in ambulatory elderly patients. J Am Geriatr Soc (1994) 1.42
Four-agent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemia. N Engl J Med (1986) 1.42
Screening for depression in hospitalized elderly medical patients: taking a closer look. J Am Geriatr Soc (1992) 1.41
Religious activity and depression among community-dwelling elderly persons with cancer: the moderating effect of race. J Gerontol B Psychol Sci Soc Sci (1998) 1.41